Lista de obras - Marina Caskey - Dominio Público Uruguay

A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract

artículo científico publicado en 2016

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals

artículo científico publicado en 2014

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

artículo científico publicado en 2017

Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

artículo científico publicado en 2007

Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

artículo científico publicado en 2016

Circulating precursors of human CD1c+ and CD141+ dendritic cells

artículo científico publicado en 2015

Clinical manifestations associated with HTLV type I infection: a cross-sectional study

artículo científico publicado en 2007

Clinical manifestations in individuals with recent diagnosis of HTLV type I infection

artículo científico publicado en 2011

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation

artículo científico publicado en 2018

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

scientific article published in Nature

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

scientific article published on 18 June 2020

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

artículo científico publicado en 2016

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

artículo científico publicado en 2012

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

artículo científico publicado en 2009

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

artículo científico publicado en 2021

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

artículo científico publicado en 2015

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro

artículo científico publicado en 2020

Enhanced SARS-CoV-2 neutralization by dimeric IgA

artículo científico publicado en 2020

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

artículo científico publicado en 2016

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

artículo científico publicado en 2016

HIV-1 integration landscape during latent and active infection

artículo científico publicado en 2015

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

artículo científico publicado en 2016

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

artículo científico publicado en 2011

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

artículo científico publicado en 2021

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells

artículo científico publicado en 2017

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

article

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

artículo científico publicado en 2016

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

artículo científico publicado en 2010

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

artículo científico publicado en 2017

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

article

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

artículo científico publicado en 2011

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

artículo científico publicado en 2008

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

artículo científico publicado en 2015

Lista de obras de Marina Caskey

A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

Circulating precursors of human CD1c+ and CD141+ dendritic cells

Clinical manifestations associated with HTLV type I infection: a cross-sectional study

Clinical manifestations in individuals with recent diagnosis of HTLV type I infection

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

HIV-1 integration landscape during latent and active infection

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.